Herold Advisors Inc. Takes $203,000 Position in Inspire Medical Systems, Inc. (NYSE:INSP)

Herold Advisors Inc. bought a new stake in Inspire Medical Systems, Inc. (NYSE:INSP) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,000 shares of the company’s stock, valued at approximately $203,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. SG Americas Securities LLC purchased a new position in Inspire Medical Systems during the third quarter valued at $1,452,000. Oak Thistle LLC bought a new stake in shares of Inspire Medical Systems in the third quarter worth about $934,000. Harbor Capital Advisors Inc. increased its stake in Inspire Medical Systems by 96.0% during the third quarter. Harbor Capital Advisors Inc. now owns 2,483 shares of the company’s stock worth $493,000 after acquiring an additional 1,216 shares during the last quarter. Commonwealth Equity Services LLC increased its stake in Inspire Medical Systems by 5.5% during the third quarter. Commonwealth Equity Services LLC now owns 7,253 shares of the company’s stock worth $1,439,000 after acquiring an additional 381 shares during the last quarter. Finally, Arcadia Investment Management Corp MI increased its stake in Inspire Medical Systems by 44.5% during the third quarter. Arcadia Investment Management Corp MI now owns 224 shares of the company’s stock worth $44,000 after acquiring an additional 69 shares during the last quarter. Institutional investors own 94.91% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on INSP. Mizuho reaffirmed a “buy” rating and set a $250.00 target price on shares of Inspire Medical Systems in a research note on Wednesday, March 27th. Royal Bank of Canada began coverage on Inspire Medical Systems in a report on Friday, April 19th. They set an “outperform” rating and a $285.00 target price for the company. KeyCorp initiated coverage on Inspire Medical Systems in a report on Tuesday, February 6th. They set an “overweight” rating and a $278.00 target price for the company. Stifel Nicolaus reiterated a “hold” rating and set a $210.00 price objective on shares of Inspire Medical Systems in a report on Tuesday, January 2nd. Finally, Truist Financial reissued a “buy” rating and issued a $280.00 target price on shares of Inspire Medical Systems in a research report on Wednesday, March 20th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $272.20.

Inspire Medical Systems Stock Up 2.8 %

INSP traded up $6.44 on Friday, reaching $237.45. The company had a trading volume of 604,202 shares, compared to its average volume of 528,640. Inspire Medical Systems, Inc. has a 1 year low of $123.27 and a 1 year high of $330.00. The stock has a market capitalization of $7.19 billion, a PE ratio of -320.88 and a beta of 1.37. The stock has a 50-day moving average price of $207.54 and a 200-day moving average price of $185.82.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.53. Inspire Medical Systems had a negative net margin of 3.39% and a negative return on equity of 3.93%. The firm had revenue of $192.51 million during the quarter, compared to analysts’ expectations of $186.75 million. During the same period in the previous year, the company earned $0.10 earnings per share. Inspire Medical Systems’s quarterly revenue was up 39.6% compared to the same quarter last year. As a group, analysts expect that Inspire Medical Systems, Inc. will post -0.35 earnings per share for the current fiscal year.

Insider Buying and Selling at Inspire Medical Systems

In other Inspire Medical Systems news, insider Randy Ban sold 12,230 shares of Inspire Medical Systems stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $185.37, for a total value of $2,267,075.10. Following the transaction, the insider now directly owns 3,029 shares in the company, valued at $561,485.73. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Inspire Medical Systems news, CFO Richard Buchholz sold 15,000 shares of the business’s stock in a transaction on Wednesday, April 17th. The stock was sold at an average price of $230.03, for a total value of $3,450,450.00. Following the completion of the transaction, the chief financial officer now directly owns 28,271 shares in the company, valued at approximately $6,503,178.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Randy Ban sold 12,230 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $185.37, for a total value of $2,267,075.10. Following the completion of the transaction, the insider now owns 3,029 shares of the company’s stock, valued at $561,485.73. The disclosure for this sale can be found here. Over the last three months, insiders have sold 76,371 shares of company stock worth $15,664,278. 4.10% of the stock is owned by company insiders.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.